Abnormal glucose tolerance in βthalassemia: Assessment of risk factors

Hemoglobin

Volumn 33, Issue 2, 2009, Pages 101-108

  Hafez, Mona ^a   Youssry, Llham ^a   El Hamed, Fayza Abd ^a   Ibrahim, Amany ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

thalassemia ( thal) major; Diabetes mellitus (dm); Homeostasis model assessment (homa); Impaired glucose tolerance (igt); Insulin resistance (ir); Insulin sensitivity; Oral glucose tolerance test (ogtt)

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN; GLUCOSE; INSULIN; IRON;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CELL FUNCTION; CHILD; CONTROLLED STUDY; EGYPT; FEMALE; FERRITIN BLOOD LEVEL; GLYCOGEN METABOLISM; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON CHELATION; IRON OVERLOAD; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SPLENECTOMY; THALASSEMIA MAJOR; BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD GLUCOSE; BLOOD TRANSFUSION; CHILD; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; RISK FACTORS; YOUNG ADULT;

EID: 67449100482     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260902817131     Document Type: Article

References (19)

1. Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, et al. Abnormal glucose tolerance in transfusion-dependent β thalassemic patients. Diabetes Care. 2001;/β24(5):850- 854.
2. Christoforidis A, Perifanis V, Tsatra I, Vlachaki E, Athanassiou-Metaxa M. Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy. Diabetes Res ClinRracl. 2007;76(1):6-11.
3. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis: Assessment by oral glucose tolerance test. Eur J I'ediatr. 2003;162(3):139-146.
4. SuvamaJ, Ingle II, Deshmukh CT. Insulin resistance and β cell function in chronically transfused patients of thalassemia major. Indian I'ediatr. 2006;43(5):393-400.
5. Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in /-thalassemia patients with and without hepatitis C virus infection. I'ediatr Endocrinol Rev. 2004;2(Suppl. 2):282-284.
6. Mangiagli A, Campisi S, De Sanctis V, Caruso Nicoletti M, Cardinale G, Galati MC, et al. Study Group of the Italian Pediatric and Diabetes Society (SIEDP) on Endocrine Complications in Non- Endocrince Disease. Effects of acarbose in /-thalassaemia major patients with normal glucose tolerance and hyperinsulinism. I'ediatr Endocrinol Rev. 2004;2(Suppl. 2):272-275.
7. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Ykijarvinen H, Van Haeften TW, et al. Use of tlie oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295-301.
8. American Diabetes Association (ADA). Screening for Type 2 Diabetes. Diabetes Care. 2004;27(Suppl. 1):S11-S14.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Dialielologia. 1985;28(7):412-419.
10. Dawson B, Trapp RG. Basic and Clinical Biostatistics. 3rd ed. New York: Lange Medical Books- McGraw-Hill; 2001.
11. Schianca GPC, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance. Importance of insulin secretion and resistance. Diabetes Care. 2003;26(5):1333-1337.
12. Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: Incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. I'ediatr Endocrinol Rev. 2004;2(Suppl. 2):285-291.
13. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, et al. Validation of the insulin sensitivity index (ISI (0, 120)): Comparison with other measures. Diabetes Res Clin I'racL 2000;47(3):166-184.
14. Angelopoulos NG, Zervas A, Livadas S, Adamopoulos, I., Giannopoulos, D., Goula, A, et al. Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major. Diabel Med. 2006;23(12):1327-1331.
15. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, et al. Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism. 1995;44(3):281-286.
16. Messina MF, Lombardo F, Meo A, Miceli M, Wasniewska M, Valenzise M, et al. Three-year prospective evaluation of glucose tolerance, β-cell function and peripheral insulin sensitivity in non- diabetic patients with thalassemia major. JEndocrinol Invest. 2002;25(6):497-501.
17. Skordis N, Michaelidou M, Sawa SC, Ioannou Y, Rousounides A, Kleanthous M, et al. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol. 2006;77(2):150-156.
18. Fernnadez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998;21(l):62-68.
19. Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major. Br J Haematol. 2006;134(4):438-444.